RBC
BMY icon

Ronald Blue & Co’s Bristol-Myers Squibb BMY Stock Holding History

Ronald Blue & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$525K Sell
9,423
-283
-3% -$15.4K 0.02% 120
2017
Q1 		$528K Buy
9,706
+117
+1% +$6.42K 0.02% 114
2016
Q4 		$560K Sell
9,589
-1,264
-12% -$69.1K 0.02% 105
2016
Q3 		$585K Buy
10,853
+625
+6% +$40.1K 0.02% 97
2016
Q2 		$753K Sell
10,228
-1,504
-13% -$106K 0.03% 85
2016
Q1 		$750K Sell
11,732
-2,458
-17% -$155K 0.04% 66
2015
Q4 		$976K Sell
14,190
-8,368
-37% -$553K 0.05% 57
2015
Q3 		$1.33M Buy
22,558
+5,265
+30% +$334K 0.07% 60
2015
Q2 		$1.15M Buy
17,293
+76
+0.4% +$5.01K 0.05% 70
2015
Q1 		$1.11M Buy
17,217
+563
+3% +$35.2K 0.05% 75
2014
Q4 		$983K Buy
16,654
+2,233
+15% +$126K 0.05% 90
2014
Q3 		$739K Sell
14,421
-709
-5% -$35.4K 0.05% 114
2014
Q2 		$734K Buy
15,130
+1,657
+12% +$81.7K 0.05% 117
2014
Q1 		$700K Sell
13,473
-3,309
-20% -$176K 0.05% 113
2013
Q4 		$892K Buy
16,782
+1,289
+8% +$65.7K 0.07% 87
2013
Q3 		$717K Buy
15,493
+6,139
+66% +$269K 0.06% 90
2013
Q2 		$418K Buy
+9,354
New +$406K 0.03% 70

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ronald Blue & Co's BMY Position: Q2 2017 in Review

Ronald Blue & Co reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q2 2017, selling an estimated $15.4K and leaving 9,423 shares worth $525K. The position accounts for 0.02% of the portfolio, ranked #120.

Ronald Blue & Co first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.33M in Q3 2015. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Ronald Blue & Co held 9,423 shares of Bristol-Myers Squibb worth $525K as of Q2 2017.
  • Ronald Blue & Co sold 283 Bristol-Myers Squibb shares in Q2 2017, an estimated $15.4K.
  • Bristol-Myers Squibb made up 0.02% of Ronald Blue & Co's portfolio in Q2 2017, its #120 holding.
  • Ronald Blue & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
  • Ronald Blue & Co's Bristol-Myers Squibb position peaked at $1.33M in Q3 2015.
  • 1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.